WallStreetZenWallStreetZen

NASDAQ: IMRX
Immuneering Corp Stock Ownership - Who owns Immuneering?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Immuneering Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Benjamin J. ZeskindPRESIDENT AND CEO2025-07-027,015$3.53
$24.79kBuy
Diana HausmanDirector2025-07-022,500$3.60
$8.99kBuy
Diana HausmanDirector2025-07-023,000$3.62
$10.87kBuy
Leah R. NeufeldCHIEF PEOPLE OFFICER2025-07-02700$3.57
$2.50kBuy
Benjamin J. ZeskindPRESIDENT AND CEO2025-07-012,985$3.38
$10.09kBuy
Thomas J. SchallDirector2025-06-279,500$3.66
$34.79kBuy
Brett Matthew HallCHIEF SCIENTIFIC OFFICER2025-06-236,007$2.43
$14.60kBuy
Harold Eugene BrakewoodChief Business Officer2025-06-201,900$2.53
$4.81kBuy
Brett Matthew HallCHIEF SCIENTIFIC OFFICER2025-06-207,415$2.70
$20.02kBuy
Peter FeinbergDirector2025-06-1825,000$2.53
$63.18kBuy

1 of 2

IMRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMRX insiders and whales buy or sell their stock.

IMRX Shareholders

What type of owners hold Immuneering Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Cormorant Asset Management LP19.55%7,099,637$60.28MInsider
Benjamin J. Zeskind10.33%3,752,706$31.86MInsider
Peter Feinberg4.02%1,460,798$12.40MInsider
Robert J. Carpenter3.16%1,148,839$9.75MInsider
Vanguard Group Inc2.91%1,056,922$8.97MInstitution
Marshall Wace LLP1.58%573,864$4.87MInstitution
Blackrock Inc1.16%422,758$3.59MInstitution
Brett Matthew Hall0.99%359,318$3.05MInsider
Southport Management LLC0.67%245,000$2.08MInstitution
Geode Capital Management LLC0.63%230,275$1.96MInstitution

1 of 3

IMRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMRX10.54%38.57%Net BuyingNet Buying
RAPT30.45%69.55%
GALT11.63%88.37%Net BuyingNet Buying
FHTX72.47%14.12%Net Buying
LXEO78.28%13.27%Net BuyingNet Selling
View Top Biotech Stocks

Immuneering Stock Ownership FAQ

Who owns Immuneering?

Immuneering (NASDAQ: IMRX) is owned by 10.54% institutional shareholders, 38.57% Immuneering insiders, and 50.88% retail investors. Cormorant Asset Management LP is the largest individual Immuneering shareholder, owning 7.10M shares representing 19.55% of the company. Cormorant Asset Management LP's Immuneering shares are currently valued at $55.80M.

If you're new to stock investing, here's how to buy Immuneering stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.